Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05069051
Title Belimumab in Patients With Chronic Lymphocytic Leukemia (BeliVeR)
Acronym BeliVeR
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital Tuebingen
Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.